Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
47303 studies found for:    (NOT NOTEXT) [CITATIONS]
Show Display Options
Download search resultsDownload the search results for:
(NOT NOTEXT) [CITATIONS] (47303 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Terminated Tenecteplase Pulmonary Embolism Italian Study
Condition: Pulmonary Embolism
Intervention: Drug: tenecteplase
2 Terminated A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)(TERMINATED)
Condition: Cancer
Intervention: Drug: VX-680 (an Aurora Kinase Inhibitor)
3 Terminated Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Condition: Sickle Cell Disease
Interventions: Drug: nitric oxide;   Drug: oxygen
4 Completed Early Home Visitation Program to Promote Good Health and Development in Children at Risk for Abuse
Condition: Child Abuse
Intervention: Behavioral: Home Visiting
5 Active, not recruiting Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
Condition: Coronary Artery Disease
6 Completed Open Thyroid Surgery With Pillow Versus no Pillow for Better Post-operative Outcomes
Condition: Post-operative Pain
Intervention: Procedure: Extended neck with standard support or pillow
7 Not yet recruiting Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)
Condition: Femoral Neck Fractures
Interventions: Procedure: Sliding Hip Screw;   Procedure: Cancellous Screws;   Dietary Supplement: Vitamin D;   Dietary Supplement: Vitamin D Placebo
8 Completed Exenatide and Metformin Therapy in Overweight Women With PCOS
Condition: Polycystic Ovary Syndrome
Intervention: Drug: metformin, exenatide or combined (metformin & exenatide )
9 Completed Aminophylline and Cognitive Function After Sevoflurane Anaesthesia
Condition: Anaesthesia
Interventions: Drug: Placebo [group P];   Drug: 0.2 mL/kg of aminophylline 10 mg/mL [group A2];   Drug: 0.2 mL/kg of aminophylline 15 mg/mL [group A3];   Drug: 0.2 mL/kg of aminophylline 20 mg/mL [group A4];   Drug: 0.2 mL/kg of aminophylline 25 mg/mL [group A5];   Drug: Doxapram 1 mg/kg [group D]
10 Terminated Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
Condition: Premature Ejaculation
Intervention: Drug: Tramadol Hydrochloride & Placebo
11 Completed Beneficial Effects of Long Term Menaquinone-7
Conditions: Bone Loss;   Arteriosclerosis
Interventions: Dietary Supplement: menaquinone-7;   Dietary Supplement: placebo
12 Completed CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners
Condition: Decision Support Systems, Clinical
Intervention: Device: CholGate
13 Active, not recruiting Adding Value in Knee Arthroplasty Post-total Knee Replacement (TKR) Care Navigator Trial
Conditions: Osteoarthritis;   Degenerative Joint Disease
Intervention: Behavioral: Care Navigator
14 Completed Culturally Adapted Cognitive Behavioral Therapy for Prevention of Self Harm
Conditions: Attempted Suicide;   Depression
Intervention: Other: Other
15 Completed Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers
Condition: Healthy Volunteer
Intervention: Drug: Raltegravir
16 Enrolling by invitation Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
Conditions: Immunologic Disorders;   Host Response;   Infectious Diseases
17 Unknown  Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
Condition: Age-Related Macular Degeneration
Intervention: Drug: Triamcinolone Acetonide
18 Active, not recruiting HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
Condition: End Stage Renal Disease (ESRD)
19 Not yet recruiting Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
Conditions: Leukemia;   Lymphoma;   Stem Cell Transplant;   Hematogenous Disorders;   Solid Tumors
Intervention: Drug: Ethanol lock therapy (ELT)
20 Completed Study of Dust Mite Inhalation in Humans
Conditions: Mild Asthma;   Allergy
Intervention: Biological: inhaled allergen challenge

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years